Pure Global

IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men - Trial NCT04865341

Access comprehensive clinical trial information for NCT04865341 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical College of Wisconsin and is currently Not yet recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 132 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04865341
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT04865341
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men
Optimizing an IMB-guided Intervention to Support HIV Self-testing and PrEP Uptake Among YMSM: A Pilot Factorial RCT

Study Focus

IMB

Interventional

behavioral

Sponsor & Location

Medical College of Wisconsin

Milwaukee, United States of America

Timeline & Enrollment

N/A

Jul 01, 2023

Jan 31, 2024

132 participants

Primary Outcome

Change in the number of self-reported HIV self-tests

Summary

The proposed study will involve adolescent (17-24 years old) men who have sex with men
 (described as YMSM hereafter) who meet eligibility criteria to participate in each study.
 Prospective study candidates will receive a copy of the IRB-approved informed consent forms
 and, if they choose to participate, will provide consent before enrollment into this study.
 Involvement of human subjects is detailed in the Research Strategy portion of this proposal,
 Recruitment and Retention Plan, and Protection of Human Subjects sections. Briefly,
 investigators will develop and pilot a randomized controlled trial (RCT) to support HIV
 self-testing (HIVST) and pre-exposure prophylaxis (PrEP) uptake. Intervention content will be
 focused on constructs of the Information-Motivation-Behavioral Skills (IMB) model. To reduce
 cost and increase feasibility, investigators plan to incorporate previously developed content
 as much as possible-investigators see integration of this content as a major strength.
 Investigators will include professionally produced videos about HIV testing and PrEP and
 other resources including the geo-targeted directories to find clinic settings that offer HIV
 testing and PrEP, all of which are publicly available. Investigators believe our approach of
 guiding YMSM through intervention modules based on theory will help improve content
 retention/use and ultimately influence constructs posited to result in behavior change.
 Investigators foresee using multiple forms of attention-matched material, media, and
 programming to engage (and retain engagement) of YMSM throughout the brief single-session
 intervention (45-60 minutes). Intervention content is subject to change depending on feedback
 from focus groups, survey results, YAB feedback, and usability testing. Primary endpoints of
 this study include HIVST and PrEP uptake, including stage of change towards HIVST and PrEP
 uptake. Secondary outcomes include changes in IMB model indicators (e.g., HIV prevention
 knowledge).

ICD-10 Classifications

Human immunodeficiency virus [HIV] disease
Unspecified human immunodeficiency virus [HIV] disease
Human immunodeficiency virus [HIV] disease resulting in other conditions
Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
Asymptomatic human immunodeficiency virus [HIV] infection status

Data Source

ClinicalTrials.gov

NCT04865341

Non-Device Trial